Authors: Roos Pouw, Eva Verheij
Release date: July 2022; reviewed/updated April 2024
This course was developed by UEG and is accredited with EACCME
All related CME accreditation is freely available upon course completion
Oesophageal adenocarcinoma is one of the most rapidly increasing cancers in the Western world and is associated with a high mortality rate. The most important risk factor for development of this type of cancer is presence of a Barrett oesophagus, of which the incidence is also increasing around the world. Patients known with Barrett oesophagus undergo regular endoscopic surveillance to detect cancer at an early and curable stage. The possibilities for endoscopic treatment of Barrett related neoplasia have enhanced significantly over the last years and this therapy has proven to be highly effective. Therefore, diagnosing and performing correct surveillance of Barrett oesophagus is becoming increasingly important.
This course includes recorded PowerPoint slides with real-time images and videos, and multiple self-assessments. The presentation is filmed in June 2022. The course has a duration of approximately 60 minutes, including the assessments. The course was developed in collaboration with the UEG.
Target audience
The target audience for this course are gastroenterologists and fellows in training, who want to gain more knowledge on Barrett oesophagus to become more experienced with this condition. Also, this course could be beneficial for all those interested in achieving better understanding of the disease and the treatment possibilities for their patients.
